Tandem has been shaping the diabetes tech landscape for years, and its next chapter shows no signs of slowing down. In a recent conversation with Liz Gasser, Tandem’s EVP and Chief Strategy Officer, we covered everything from Dexcom G7 integration to the long-awaited Mobi pump and the development of a fully tubeless system called Sigi. Each piece offers a glimpse into the company’s broader vision: building a smarter, more flexible ecosystem that adapts to the way people actually live.

Dexcom G7 support has been one of the most anticipated updates, and the integration reflects how far the technology has come. Faster warmups, a slimmer profile, and better connectivity all translate into fewer interruptions and more seamless automated insulin delivery. That kind of tight coordination between pump and CGM is something users have been asking for, and now it’s becoming standard across Tandem’s platforms.

A lot of excitement has also been centered around the Mobi pump—a small, lightweight device designed for flexibility and discretion. Mobi supports full automated insulin delivery, allows charging without disconnecting, and gives users more options for wearing, clipping, or carrying the pump. It represents Tandem’s push toward making pump therapy feel less like a device you manage and more like something that blends into daily life.

And then there’s Sigi—the pump that helps bring Tandem into the tubeless-first market. Unlike Tandem’s current tubed pumps, Sigi is being developed as a fully tubeless system that maintains the customizability and safety of Tandem’s existing hardware while removing the tubing altogether. It’s still in development, but the direction is clear: Tandem wants to offer the best of both worlds—a modular ecosystem where users can choose between tubed or tubeless without leaving the platform they trust.

The road ahead is full of innovation, and each step brings the industry closer to pumps that are smaller, smarter, and easier to live with. If you want the full conversation with Liz Gasser—including deeper insights into timelines, design decisions, and what Tandem sees coming next—be sure to check out the full YouTube episode below and the podcast above.

Disclaimer: Diabetech content is not medical advice—it’s for educational purposes only. Always consult with a physician before making changes to your healthcare.